---
id: 201
title: Sepsis and Septic Shock Management
category: clinical_syndromes
subcategory: critical_care
tags: [sepsis, septic-shock, sepsis-3, lactate, SOFA, surviving-sepsis, early-goal-directed-therapy]
difficulty: high
---

## Question

How is septic shock managed? Use **"Sepsis-3: Infection + SOFA ≥2, Shock: Lactate >2 + Vasopressors → Antibiotics <1h, Fluids 30mL/kg, Norepinephrine"** framework.

## Answer

### **Definitions (Sepsis-3):**

**Sepsis:**
- **Life-threatening organ dysfunction** due to dysregulated host response to infection
- **SOFA score increase ≥2 points** (from baseline)

**Septic Shock:**
- **Sepsis** + **persistent hypotension requiring vasopressors** (MAP ≥65 mmHg) + **lactate >2 mmol/L** despite adequate fluid resuscitation

**qSOFA (Quick SOFA - Bedside Screening):**
- **≥2 of 3:** Altered mental status, SBP ≤100 mmHg, RR ≥22/min
- **Suggests organ dysfunction** (higher mortality risk)

### **Initial Resuscitation (Hour 1 Bundle):**

**1. Measure Lactate:**
- **Lactate ≥2 mmol/L** = tissue hypoperfusion
- **Remeasure within 2-4h** if elevated (guide resuscitation)

**2. Obtain Blood Cultures (Before Antibiotics):**
- **≥2 sets** (aerobic + anaerobic, from different sites)
- **Do NOT delay antibiotics >45 min** for cultures

**3. Broad-Spectrum Antibiotics (Within 1 Hour):**
- **Every hour delay = ↑mortality 7-8%**
- **Empiric coverage** based on suspected source, local resistance

**4. Fluid Resuscitation:**
- **30 mL/kg crystalloid IV within 3 hours** (initial bolus)
- **Balanced crystalloids** (LR, Plasmalyte) OR normal saline
- **Reassess frequently** (avoid fluid overload)

**5. Vasopressors (If Hypotension Persists):**
- **Norepinephrine** (first-line) - target MAP ≥65 mmHg
- **Start promptly** if hypotension persists despite fluids

### **Empiric Antibiotics:**

**Unknown Source:**
- **Vancomycin 15-20 mg/kg IV** + **piperacillin-tazobactam 3.375-4.5g IV q6-8h** OR **cefepime 2g IV q8h + metronidazole 500mg IV q8h**

**Suspected Source-Specific:**

| Source | Empiric Regimen |
|--------|-----------------|
| **Pneumonia** | Ceftriaxone 2g IV daily + azithromycin 500mg IV daily OR levofloxacin 750mg IV daily |
| **Intra-abdominal** | Pip-tazo OR cefepime + metronidazole OR carbapenem |
| **Urinary** | Ceftriaxone OR cefepime OR fluoroquinolone (+ vancomycin if MRSA risk) |
| **Skin/soft tissue** | Vancomycin + pip-tazo OR carbapenem (necrotizing: add clindamycin) |
| **Unknown + immunocompromised** | Vancomycin + cefepime + metronidazole (consider antifungal) |

**De-escalate** based on cultures/susceptibilities (narrow spectrum, stop unnecessary agents)

### **Vasopressor Management:**

**First-Line:**
- **Norepinephrine** 0.05-2 mcg/kg/min (target MAP ≥65 mmHg)

**Second-Line (If Inadequate Response):**
- **Vasopressin** 0.03-0.04 units/min (add to norepinephrine, NOT replace)
- **Epinephrine** 0.05-2 mcg/kg/min (if refractory)

**Add Dobutamine:**
- **If cardiac dysfunction** with evidence of hypoperfusion despite adequate MAP/filling pressures

**Avoid:**
- **Dopamine** (higher arrhythmia risk vs. norepinephrine)

### **Adjunctive Therapies:**

**Source Control:**
- **Drain abscesses, remove infected devices, debride necrotic tissue**
- **Within 12 hours** (if feasible)

**Corticosteroids (If Refractory Shock):**
- **Hydrocortisone 50mg IV q6h** OR **200mg/day continuous infusion**
- **Indications:** Requiring escalating vasopressors despite fluids
- **Duration:** Until shock resolves, then taper

**Lactate Clearance:**
- **Repeat lactate in 2-4h** if initially elevated
- **Goal:** Normalize lactate (<2 mmol/L) OR decrease ≥10% per 2h

**Blood Transfusion:**
- **Restrictive strategy:** Transfuse if Hb <7 g/dL (unless active bleeding, myocardial ischemia)

**Mechanical Ventilation (If ARDS):**
- **Low tidal volume** (6 mL/kg ideal body weight)
- **Plateau pressure <30 cm H₂O**

### **Monitoring:**

**Targets:**
- **MAP ≥65 mmHg**
- **Urine output ≥0.5 mL/kg/h**
- **Lactate clearance** (normalize or ↓10% per 2h)
- **ScvO₂ ≥70%** (if available, central venous catheter)

**Serial Assessments:**
- **Physical exam:** Skin perfusion, mental status, urine output
- **Labs:** Lactate (q2-4h), ABG, electrolytes, renal function
- **Echocardiography:** If unclear volume status or refractory shock

### **Common Pitfalls:**

**Delayed Antibiotics:**
- **Most common error** (every hour delay ↑mortality)
- **Give within 1 hour** of recognition

**Excessive Fluids:**
- **Fluid overload** → pulmonary edema, prolonged ventilation
- **Reassess after each bolus** (dynamic measures: passive leg raise, pulse pressure variation if applicable)

**Wrong Vasopressor:**
- **Norepinephrine = first-line** (NOT dopamine, phenylephrine)

**Inadequate Source Control:**
- **Persistent infection** despite antibiotics (abscess, infected device)

## Key Points

### **Sepsis-3 Definition:**
- **Sepsis:** Infection + SOFA ≥2
- **Septic shock:** Sepsis + vasopressors (MAP ≥65) + lactate >2 mmol/L

### **Hour 1 Bundle:**
- **Measure lactate**
- **Blood cultures before antibiotics**
- **Broad-spectrum antibiotics <1 hour**
- **30 mL/kg crystalloid** (if hypotensive or lactate ≥4)
- **Vasopressors** if hypotension persists

### **Antibiotics <1 Hour:**
- **Every hour delay = ↑mortality 7-8%**
- **Broad empiric → de-escalate** based on cultures

### **Norepinephrine = First-Line Vasopressor:**
- **Target MAP ≥65 mmHg**
- **Add vasopressin** if inadequate response

### **Source Control:**
- **Drain abscesses, remove infected devices** (within 12h if feasible)

### **Clinical Pearls:**
- **Septic shock:** Infection + hypotension requiring vasopressors + lactate >2 mmol/L
- **Hour 1 bundle:** Lactate, cultures, antibiotics <1h, 30 mL/kg fluids, vasopressors if needed
- **Norepinephrine first-line** (target MAP ≥65 mmHg)
- **Source control** within 12h (drain, debride, remove devices)
- **De-escalate antibiotics** based on cultures (narrow spectrum, stop unnecessary)

## Sources

- [Surviving Sepsis Campaign Guidelines 2024]
- [JAMA: Sepsis-3 Definitions 2024]

## Media

N/A
